Nerve Graft Conduit Platform

About Swan NeuroTech

Swan NeuroTech is a private, pre-revenue biotech company advancing a novel platform for peripheral nerve regeneration. The company's technology centers on tunable polymer-based nerve graft conduits integrated with controlled drug delivery via polymer microspheres, manufactured using a proprietary additive manufacturing process. Targeting a significant unmet medical need with an estimated $20B annual US healthcare cost burden, Swan NeuroTech is in the pre-clinical development stage, leveraging a team and advisory board with strong expertise in regenerative medicine, polymer science, and clinical neurology. The company appears to be in a foundational R&D phase, building its technology portfolio and team.

Therapeutic Areas